Home Newsfeeds Goldman Sachs Maintains Neutral on BioNTech, Lowers Price Target to $156

Goldman Sachs Maintains Neutral on BioNTech, Lowers Price Target to $156

Goldman Sachs analyst Chris Shibutani maintains BioNTech (NASDAQ:BNTX) with a Neutral and lowers the price target from $177 to $156.

byBenzinga Newsdesk

January 31, 2023

1 minute read

Goldman Sachs analyst Chris Shibutani maintains BioNTech (NASDAQ:BNTX) with a Neutral and lowers the price target from $177 to $156.

Baird Maintains Neutral on Oshkosh, Lowers Price Target to $83

By Benzinga Newsdesk

July 29, 7:47 AM

Baird analyst Mircea Dobre maintains Oshkosh (NYSE:OSK) with a Neutral and lowers the price target from $84 to $83.

OSK

News
Tech

ARK Invest Sees Cruise, Waymo Expansion Pave Way For Tesla’s Robotaxi

By Anan Ashraf

August 1, 3:36 AM

On Monday, an analyst from Cathie Wood-led ARK Investment Management shared a prospective aftermath of the Cruise expansion…

Alset And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

By Lisa Levin

July 3, 7:08 AM

The Dow Jones closed higher by over 280 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AEI

Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day

By Avi Kapoor

December 12, 3:22 AM

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow Jones index recording its highest close since Jan. 2022.

Goldman Sachs Maintains Neutral on BioNTech, Lowers Price Target to $156

Related Posts

Baird Maintains Neutral on Oshkosh, Lowers Price Target to $83

ARK Invest Sees Cruise, Waymo Expansion Pave Way For Tesla’s Robotaxi

Alset And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day